Paper Key : IRJ************653
Author: Rohit Bharat Ghodge
Date Published: 14 Oct 2023
Abstract
Drug-related problems could significantly affect the clinical results in critically ill patients. Due to frequent medication-related occurrences and difficult clinical courses, critically ill patients are typically thought to be more prone to harm from drug-related problems. Drug-related problems (DRPs) are common during hospitalisation as there may be multiple modifications to the patients drug regimen and a lack of continuity of treatment. The purpose of the current study was to evaluate the pharmacist interventions in a teaching hospital for tertiary care, identify DRPs, drug classes involved in DRPs, and associated factors with their incidence.The business of producing illegal drugs is increasing, and India has turned into a place where they are dumped. All of the formulations are intended for the prevention or treatment of illnesses and diseases, but only a small number of the medications are actually necessary for survival; the remainder are merely substitutes for one another. Due to a lack of law enforcement physician awareness and the drug control authorities failure to tell all hospitals of the status of medicine, prohibited drugs are still accessible in developing nations like India. Some of the hazardous medicines have been banned globally, currently they are still available in India. The US FDA has banned the most popular over-the-counter medications, including NIMESULIDE, FURAZOLIDONE, PHENYLPROPANOLAMINE, because of their negative effects on the kidney, liver, and nervous system. Here in the review paper we try to cover some drugs which are banned in India and other countries with there ADR DPRs.
DOI LINK : 10.56726/IRJMETS45243 https://www.doi.org/10.56726/IRJMETS45243